Krystal Biotech buy Guggenheim
Start price
28.02.23
/
50%
€77.50
Target price
28.02.24
€95.04
Performance (%)
93.55%
End price
29.02.24
€150.00
Summary
This prediction ended on 29.02.24 with a price of €150.00. The BUY prediction by Guggenheim for Krystal Biotech saw massive gains of 93.55%. Guggenheim has a follow-up prediction for Krystal Biotech where he still thinks Krystal Biotech is a Buy. Guggenheim has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Krystal Biotech | 1.096% | 1.096% | 52.264% |
iShares Core DAX® | -1.114% | 3.430% | 25.966% |
iShares Nasdaq 100 | 1.816% | 6.911% | 30.390% |
iShares Nikkei 225® | 2.113% | 5.501% | 23.404% |
iShares S&P 500 | 2.038% | 5.327% | 30.881% |
Comments by Guggenheim for this prediction
In the thread Krystal Biotech diskutieren
Krystal Biotech, Inc. (NASDAQ: KRYS) had its "buy" rating re-affirmed by analysts at Guggenheim. They now have a $101.00 price target on the stock.
Ratings data for KRYS provided by MarketBeat
In the thread Trading Krystal Biotech
Die von Guggenheim gewählte maximale Laufzeit wurde überschritten